-+ 0.00%
-+ 0.00%
-+ 0.00%

HCW Biologics Regains Nasdaq Compliance

Benzinga·03/02/2026 13:14:19
Listen to the news

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and disease, today reported that, on February 26, 2026, the Nasdaq Hearings Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq" or the "Exchange") found that the Company regained compliance with all continued listing rules of The Nasdaq Capital Market.